Literature DB >> 17848808

IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model.

Laurence Van Overtvelt1, Vincent Lombardi, Alain Razafindratsita, Nathalie Saint-Lu, Stéphane Horiot, Hélène Moussu, Laurent Mascarell, Philippe Moingeon.   

Abstract

BACKGROUND: IL-10-inducing adjuvants could enhance the efficacy of allergy vaccines in establishing allergen-specific tolerance. The aim of this study was to identify such adjuvants using in vitro cultures of human and murine cells and to evaluate them in a therapeutic murine model of sublingual immunotherapy (SLIT).
METHODS: Adjuvants stimulating IL-10 gene expression by human or murine immune cells were tested sublingually in BALB/c mice sensitized to ovalbumin (OVA), assessing the reduction in airway hyperresponsiveness (AHR) by whole-body plethysmography. The induction of regulatory T cells (T(reg)) was evaluated using phenotypic and functional assays. T-cell proliferation in cervical lymph nodes (LNs) was assessed following intravenous transfer of CFSE-labelled OVA-specific T cells and FACS analysis.
RESULTS: A combination of 1,25-dihydroxyvitamin D3 plus dexamethasone (VitD3/Dex) as well as Lactobacillus plantarum were found to induce IL-10 production by human and murine dendritic cells (DCs). The former inhibits LPS-induced DC maturation, whereas L. plantarum induces DC maturation. Following stimulation with VitD3/Dex-pretreated DCs, CD4+ naïve T cells exhibit a T(reg) profile. In contrast, a Th1/T(reg) pattern of differentiation is observed in the presence of DCs treated with L. plantarum. Both adjuvants significantly enhance SLIT efficacy in mice, in association with either induction of Foxp3+ T(reg) cells (for VitD3/Dex) or proliferation of OVA-specific T cells in cervical LNs (for L. plantarum).
CONCLUSIONS: Both VitD3/Dex and L. plantarum polarize naïve T cells towards IL-10-expressing T cells, through distinct mechanisms. As adjuvants, they both enhance SLIT efficacy in a murine asthma model. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17848808     DOI: 10.1159/000108140

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  24 in total

Review 1.  Tolerizing allergic responses in the lung.

Authors:  C M Lloyd; J R Murdoch
Journal:  Mucosal Immunol       Date:  2010-05-26       Impact factor: 7.313

2.  Cutting edge: Immunosuppressant as adjuvant for tolerogenic immunization.

Authors:  Youmin Kang; Lipeng Xu; Bin Wang; Aoshuang Chen; Guoxing Zheng
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

3.  NOD1 in the modulation of host-microbe interactions and inflammatory bone resorption in the periodontal disease model.

Authors:  João Antônio Chaves de Souza; Sabrina Cruz Tfaile Frasnelli; Fabiana de Almeida Curylofo-Zotti; Mário Julio Ávila-Campos; Luis Carlos Spolidório; Dario Simões Zamboni; Dana T Graves; Carlos Rossa
Journal:  Immunology       Date:  2016-09-06       Impact factor: 7.397

Review 4.  Strategies of mucosal immunotherapy for allergic diseases.

Authors:  Yi-Ling Ye; Ya-Hui Chuang; Bor-Luen Chiang
Journal:  Cell Mol Immunol       Date:  2011-06-13       Impact factor: 11.530

5.  Immunization of mice with Lactobacillus casei expressing a beta-intimin fragment reduces intestinal colonization by Citrobacter rodentium.

Authors:  P C D Ferreira; J B da Silva; R M F Piazza; L Eckmann; P L Ho; M L S Oliveira
Journal:  Clin Vaccine Immunol       Date:  2011-09-07

Review 6.  Adjuvants for allergy vaccines.

Authors:  Philippe Moingeon
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

Review 7.  Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases.

Authors:  Charles B Smarr; Paul J Bryce; Stephen D Miller
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

8.  Sublingual immunotherapy in allergic asthma: Current evidence and needs to meet.

Authors:  Cristoforo Incorvaia; Gian Galeazzo Riario-Sforza; Stefano Incorvaia; Franco Frati
Journal:  Ann Thorac Med       Date:  2010-07       Impact factor: 2.219

Review 9.  Towards a cure for food allergy.

Authors:  Justin M Skripak; Hugh A Sampson
Journal:  Curr Opin Immunol       Date:  2008-10-23       Impact factor: 7.486

Review 10.  Probiotics and immunity.

Authors:  Andrea T Borchers; Carlo Selmi; Frederick J Meyers; Carl L Keen; M Eric Gershwin
Journal:  J Gastroenterol       Date:  2009-01-22       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.